Resection of hepatocellular adenoma in patients with glycogen storage disease type Ia.

Resection of hepatocellular adenoma in patients with glycogen storage disease type Ia. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Resection of hepatocellular adenoma in patients with glycogen storage disease type Ia. Abstract Text:

Srinevas K Reddy,Priya S Kishnani,Jennifer A Sullivan,Dwight D Koeberl,Dev M Desai,Michael A Skinner,Henry E Rice,Bryan M Clary,Srinevas K Reddy,Priya S Kishnani,Jennifer A Sullivan,Dwight D Koeberl,Dev M Desai,Michael A Skinner,Henry E Rice,Bryan M Clary,Srinevas K Reddy,Priya S Kishnani,Jennifer A Sullivan,Dwight D Koeberl,Dev M Desai,Michael A Skinner,Henry E Rice,Bryan M Clary,

BACKGROUND/AIMS: Because dietary modifications have prolonged the life expectancy of patients with glycogen storage disease type Ia (GSD Ia), the incidence of hepatocellular adenoma (HCA) to carcinoma (HCC) transformation is increasing. The objective of this retrospective study is to assess the safety and effectiveness of HCA resection in GSD Ia patients. METHODS: Clinicopathologic, peri-operative, and long-term data were reviewed from patients who underwent HCA resection. Comparisons were made with Fisher's exact, Mann-Whitney U, and log-rank tests; survival was estimated with Kaplan-Meier analysis. RESULTS: From 1998 to 2006, 38 patients underwent HCA resection. Seven (22%) had GSD Ia. Post-operative mortality occurred in one GSD Ia patient. GSD Ia patients had greater morbidity (86% vs. 20%) and shorter time to adenoma progression (median 23 months vs. not yet reached) after partial hepatectomy compared to the general population (p<0.05). Six GSD Ia patients had no evidence of HCC and recovered after resection without long-term morbidity. Three GSD Ia patients underwent liver transplantation 77, 32, and 23 months after adenoma resection. CONCLUSIONS: Despite substantial morbidity, partial hepatectomy is feasible in GSD Ia patients and is an effective intermediate step in the prevention of HCC until definitive treatment with liver transplantation.

Resection of hepatocellular adenoma in patients with glycogen storage disease type Ia. Publishing Authors By Initials

SK Reddy,PS Kishnani,JA Sullivan,DD Koeberl,DM Desai,MA Skinner,HE Rice,BM Clary,SK Reddy,PS Kishnani,JA Sullivan,DD Koeberl,DM Desai,MA Skinner,HE Rice,BM Clary,SK Reddy,PS Kishnani,JA Sullivan,DD Koeberl,DM Desai,MA Skinner,HE Rice,BM Clary,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Resection of hepatocellular adenoma in patients with glycogen storage disease type Ia. Journal Published:

PUBLICATION TYPE: Research Support, Non-U.S. Gov

Journal: Journal of hepatology

VOLUME: 47

Page Numbers: 658-63

Journal Abbreviation: J. Hepatol.

ISSN: 0168-8278

DAY: 18

MONTH: 06

YEAR: 2007

Resection of hepatocellular adenoma in patients with glycogen storage disease type Ia. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 8503886

Resection of hepatocellular adenoma in patients with glycogen storage disease type Ia. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Resection of hepatocellular adenoma in patients with glycogen storage disease type Ia. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Resection of hepatocellular adenoma in patients with glycogen storage disease type Ia.

AFFILIATION: Department of Surgery, Duke University Medical Center, Box 3247, Durham, NC 27710, USA. reddy005@mc.duke.edu

Country: England

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: J Hepatol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Resection of hepatocellular adenoma in patients with glycogen storage disease type Ia Related Publications

• Addition of bevacizumab to irinotecan- and oxaliplatin-based preoperative chemotherapy regimens does not increase morbidity after resection of colorectal liver metastases.
• Chemical Dynamics Special Feature: Theoretical studies on bimolecular reaction dynamics.
• Dual-phase 3D MDCT angiography for evaluation of the liver before hepatic resection.
• INTERNAL HEMORRHOIDS IN AN INFANT.
• Inhibition of in vivo tumor angiogenesis and growth via systemic delivery of an angiopoietin 2-specific RNA aptamer.
• Quantum dynamics of chemical reactions.
• RECTOVAGINAL FISTULA IN INFANCY: REPORT OF CASE.
• REMARKS ON BANDAGING.
• RNA Aptamer-targeted Inhibition of NF-kappaB Suppresses Non-small Cell Lung Cancer Resistance to Doxorubicin.
• Resection of hepatocellular adenoma in patients with glycogen storage disease type Ia.
• Simultaneous Resections of Colorectal Cancer and Synchronous Liver Metastases: A Multi-institutional Analysis.
• Use of bioluminescence imaging to detect enhanced hepatic and systemic tumor growth following partial hepatectomy in mice.
• [Synergistic treatment of Hansen's disease by bimonthly injections of diaminodiphenyl-sulfone-thioacetazone in a chaulmoogra medium.]